Get Control of Your
Specialty Drug Spend
With so many moving parts, plan sponsors can’t be expected to master every detail of their prescription benefits programs. They need expert guidance, a partner well-equipped to navigate contract pitfalls and make their programs as efficient as possible. That’s where ELMCRx comes in.
ELMCRx develops and manages programs that deliver real cost savings, superior risk management and clinical design that’s sustainable over the long term. With real-time contract oversight and advanced performance analytics, we negotiate best terms and ensure that all requirements are being fulfilled.
If you’re a plan sponsor looking for a partner to optimize your pharmacy benefits plan, look no further than us.
In 2020 Specialty Medication costs
accounted for approximately
of spend, up from 25% in 2013
Cost Containment
Programs
Eliminate cost from the pharmacy benefit delivery system through objective, unbiased review.
Clinical
Management
Evaluate the effectiveness of clinical management for high-cost medications.
ELMCRx Solutions Announces Strategic Partnership with Peek, Enhancing Rx Management Capabilities
October 31, 2024 Wayne, PA —ELMCRx Solutions (“ELMCRx”), a leading pharmacy benefit management (PBM) solutions provider, is pleased to announce a strategic partnership with Peek Healthcare Technologies Inc. (“Peek”). Peek’s prescription marketplace offers patients a full view of prescription costs, Read More
ELMCRx Solutions Announces the Appointment of Amy Gasbarro as President, Paving the Way for Strategic Growth and Innovation
September 16, 2024 Wayne, PA — ELMCRx Solutions (“ELMCRx”), a leading provider and consolidator of pharmacy benefit management (PBM) point solutions, is pleased to announce the appointment of Amy Gasbarro as President. Amy brings decades of leadership and experience in Read More
ELMCRx Highlighted in SIIA’s The Self-Insurer on Alternative Rx Funding
July 9, 2024 Mary Ann Carlisle, COO of ELMCRx Solutions, discusses the increasing necessity for alternative funding solutions in prescription drug markets. Authored by Bruce Shutan, the article explores innovative strategies such as patient assistance programs (PAPs) and federal subsidies Read More
Members of the ELMCRx team were recently featured in SIIA’s article on Wellness Programs
Aug 14, 2023 At the nexus of obesity and diabetes comes a new genre of blockbuster weight loss medications, which the media characterizes as the “Hollywood diet drugs.” While these medications are designed for people with Type 2 diabetes, they Read More